GlassScriptPhysician profile
Andre P Broussard
NPI 1407147291
$2,663.86
in general payments reported to CMS, 2019-2025
33 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $180 · 2021: $637 · 2022: $512 · 2023: $417 · 2024: $351 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,107.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $477.16 | 2021-2025 | Stratafix, Evarrest, Echelon; Endopath |
| Pfizer INC. | $265.48 | 2021-2024 | |
| Teleflex LLC | $243.10 | 2021-2023 | Urolift |
| Coloplast Corp | $229.05 | 2019-2022 | |
| Baxter Healthcare | $149.50 | 2020 | |
| Astellas Pharma US INC | $131.98 | 2019-2025 | Xtandi |
| Edwards Lifesciences Corporation | $101.91 | 2023 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $97.21 | 2021-2023 | Ams 800 Artificial Urinary Sphincter |
| Abbvie INC. | $88.72 | 2024 | |
| Merck Sharp & Dohme LLC | $79.20 | 2020-2025 | Keytruda, Lynparza |
| Endo Pharmaceuticals INC. | $71.87 | 2019-2023 | Xiaflex |
| Cook Medical LLC | $65.74 | 2019-2025 | Cook Celect |
| Myovant Sciences INC. | $63.72 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $60.63 | 2023 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $59.16 | 2022-2025 | Provenge |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $53.00 | 2025 | |
| Inari Medical, INC. | $48.67 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Urogen Pharma, INC. | $40.76 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.55 | 2022-2023 | |
| Zyla Life Sciences, INC. | $31.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $30.13 | 2024-2025 | |
| Argon Medical Devices, INC. | $25.43 | 2025 | Clot Management |
| Allergan, INC. | $24.29 | 2019 | |
| Urovant Sciences INC | $24.26 | 2022 | |
| Procept Biorobotics Corporation | $21.69 | 2024 | Aquabeam System |
| Tolmar Pharmaceuticals, INC. | $21.44 | 2022 | |
| Blue Earth Diagnostics | $20.95 | 2022 | |
| Telix Pharmaceuticals | $18.84 | 2024 | Illuccix |
| Axonics, INC. | $17.99 | 2021 | |
| Janssen Biotech, INC. | $17.23 | 2022 | |
| Tolmar, INC. | $16.88 | 2024 | |
| Acacia Pharma INC | $16.35 | 2022 | |
| Srs Medical Systems, INC. | $12.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Broussard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.